Origin Investment Corp I ORIQ
Last close
10.40
2026-09-01
Market cap
$89.7M
2026-06-30 share count
52-week range
9.98 - 10.40
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| SG&A | $678.2K | — |
| Total operating expenses | $678.2K | — |
| Net income | $683.1K | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | $1.2M | $0 |
| Total current assets | $1.3M | $269.9K |
| Total assets | $72.3M | $269.9K |
| Accounts payable | $174.9K | — |
| Total current liabilities | $174.9K | $253.2K |
| Total liabilities | $174.9K | $253.2K |
| Retained earnings | $674.9K | -$8.2K |
| Total equity | $1.1M | $16.8K |
Cash flow
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Operating cash flow | -$694.7K | — |
| Investing cash flow | -$69.7M | — |
| Financing cash flow | $71.5M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-013616.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $647.8M | — | — |
| IACO | Idea Acquisition Corp. | $437.1M | — | — |
| KRAQ | KRAKacquisition Corp | $431.6M | — | — |
| TACO | Berto Acquisition Corp. | $393.6M | 36.2x | — |
| ALDF | Aldel Financial II Inc. | $322.7M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $315.1M | — | — |
| FGII | FG Imperii Acquisition Corp. | $289.7M | — | — |
| SOUL | Soulpower Acquisition Corp. | $268.0M | — | — |